BillionToOne, Inc.
Rank #237HypergrowthBLLN · Nasdaq · Healthcare
BillionToOne, Inc. (BLLN) — Rank #237 by gross profitability (GP/assets 0.29) · ROE 1.4% · Piotroski F-Score 7 / 9.
As-of 2026-09-15 · CIK 0002070849 · all metrics point-in-time as of the filing date.
About
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics.
Show moreShow less
The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc.
was incorporated in 2016 and is headquartered in Menlo Park, California.
- Industry
- Diagnostics & Research
- Sector
- Healthcare
- State
- DE
- Filer Category
- Non-accelerated filerEmerging growth company
- Fiscal Year End
- December 31
- Website
- billiontoone.com
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-03-11 | 2024-12-31filed 2026-03-11 | 2023-12-31filed 2026-03-11 |
|---|---|---|---|
| Assets | |||
| Cash & equivalents | 496.0 | 191.5 | 97.3 |
| Accounts receivable | 41.6 | 24.7 | — |
| Inventory | 17.5 | 8.7 | — |
| Total current assets | 560.6 | 227.8 | — |
| Property, plant & equipment, net | 20.4 | 17.1 | — |
| Total assets | 632.7 | 302.1 | — |
| Liabilities | |||
| Accounts payable | 7.2 | 4.3 | — |
| Deferred revenue | 2.2 | 2.8 | 3.0 |
| Total current liabilities | 48.0 | 28.4 | — |
| Total debt | 57.2 | 51.5 | — |
| Total liabilities | 152.5 | 134.3 | — |
| Equity | |||
| Retained earnings | (274.7) | (282.2) | — |
| Total shareholders' equity | 480.1 | (251.7) | (219.1) |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?